VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has today executed a binding agreement for the sale of its wholly owned subsidiary Invictus BioPharma Pty Ltd.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that the United States Patent and Trademarks Office (USPTO) intends to grant a divisional patent for the 'Transmucosal Delivery of Tocotrienols' to its wholly-owned subsidiary Invictus Biotechnology Pty Ltd.
As the world emerges from the pandemic which has emphasised the critical importance of vaccination, Apiam Animal Health (ASX:AHX) has identified an opportunity to position Australia as leaders in autogenous vaccine manufacturing.
Apiam Animal Health Limited (ASX:AHX) has been at the forefront of animal health standards of care. But with one eye on their international counterparts, executives at Apiam foresee some major improvements in animal, customer and employee outcomes which will be driven by technology.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting an abstract at the American Society for Nutrition (ASN) Annual Conference, Nutrition 2022.
Nanollose Limited (ASX:NC6) (FRA:N0L) is commercialising scalable technology to create tree-free fibres with minimal environmental impact.
iQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
